| Sep 23 |
Bio-Rad Laboratories: Overvalued Given Current Growth Prospects
|
| Sep 9 |
Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next?
|
| Aug 22 |
Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference
|
| Aug 22 |
Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now
|
| Aug 20 |
Bio-Rad Laboratories appoints DiVincenzo as COO
|
| Aug 20 |
Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
|
| Aug 12 |
Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure
|
| Aug 6 |
Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and Diagnosis Stock Right Now?
|
| Aug 2 |
Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Bio-Rad Laboratories plummets 20% on updated 2024 outlook
|
